Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias

Ming Hsiung Hsieh, Shih Ann Chen, Zu Chin Wen, Ching Tai Tai, Chern En Chiang, Yu An Ding, Mau Song Chang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

For conversion of atrial fibrillation to sinus rhythm and management of ventricular arrhythmias, antiarrhythmic drugs were frequently used. However, the effects of antiarrhythmic drugs on exercise performance and on the variability of ventricular rate were not available. This study included 37 patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias. The patients were divided into three groups and received sotalol, propafenone, and procainamide, respectively. Before and after taking the drugs for 14 days, these patients received treadmill exercise test, 24 h Holter electrocardiogram, and tilt table test for evaluation of the exercise performance and the variability of ventricular rate (including the mean RR intervals, mRR, the standard deviation of RR intervals, SDRR, and the root mean square of the difference in successive RR intervals, rMSSD). All these antiarrhythmic drugs could suppress ventricular arrhythmia but only sotalol could significantly increase the exercise duration (374 ± 50 to 476 ± 55 s, P=0,02), and reduce the maximal heart rate (186 ± 23 to 136 ± 16 beats/min, P=0.01) during exercise test. Furthermore, only sotalol increased the mRR (777 ± 60 to 885 ± 66 ms, P=0.02), SDRR (190 ± 40 to 216 ± 48 ms, P=0.04) and rMSSD (223 ± 48 to 253 ± 40 ms, P=0.03) during 24 h Holter electrocardiogram. With head-up tilt, the mRR, SDRR and rMSSD all decreased significantly before drug therapy, and these changes were still present only after propafenone therapy. Therefore, comparisons among sotalol, propafenone and procainamide showed that sotalol increased the exercise performance and the variability of ventricular rate in patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias.

Original languageEnglish
Pages (from-to)37-45
Number of pages9
JournalInternational Journal of Cardiology
Volume64
Issue number1
DOIs
Publication statusPublished - Mar 13 1998
Externally publishedYes

Fingerprint

Sotalol
Anti-Arrhythmia Agents
Atrial Fibrillation
Cardiac Arrhythmias
Propafenone
Exercise
Exercise Test
Procainamide
Electrocardiography
Tilt-Table Test
Heart Rate
Head
Drug Therapy
Pharmaceutical Preparations

Keywords

  • Antiarrhythmic drugs
  • Atrial fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias. / Hsieh, Ming Hsiung; Chen, Shih Ann; Wen, Zu Chin; Tai, Ching Tai; Chiang, Chern En; Ding, Yu An; Chang, Mau Song.

In: International Journal of Cardiology, Vol. 64, No. 1, 13.03.1998, p. 37-45.

Research output: Contribution to journalArticle

Hsieh, Ming Hsiung ; Chen, Shih Ann ; Wen, Zu Chin ; Tai, Ching Tai ; Chiang, Chern En ; Ding, Yu An ; Chang, Mau Song. / Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias. In: International Journal of Cardiology. 1998 ; Vol. 64, No. 1. pp. 37-45.
@article{5c37ecb03f384a679cd39579ec6f0fe4,
title = "Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias",
abstract = "For conversion of atrial fibrillation to sinus rhythm and management of ventricular arrhythmias, antiarrhythmic drugs were frequently used. However, the effects of antiarrhythmic drugs on exercise performance and on the variability of ventricular rate were not available. This study included 37 patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias. The patients were divided into three groups and received sotalol, propafenone, and procainamide, respectively. Before and after taking the drugs for 14 days, these patients received treadmill exercise test, 24 h Holter electrocardiogram, and tilt table test for evaluation of the exercise performance and the variability of ventricular rate (including the mean RR intervals, mRR, the standard deviation of RR intervals, SDRR, and the root mean square of the difference in successive RR intervals, rMSSD). All these antiarrhythmic drugs could suppress ventricular arrhythmia but only sotalol could significantly increase the exercise duration (374 ± 50 to 476 ± 55 s, P=0,02), and reduce the maximal heart rate (186 ± 23 to 136 ± 16 beats/min, P=0.01) during exercise test. Furthermore, only sotalol increased the mRR (777 ± 60 to 885 ± 66 ms, P=0.02), SDRR (190 ± 40 to 216 ± 48 ms, P=0.04) and rMSSD (223 ± 48 to 253 ± 40 ms, P=0.03) during 24 h Holter electrocardiogram. With head-up tilt, the mRR, SDRR and rMSSD all decreased significantly before drug therapy, and these changes were still present only after propafenone therapy. Therefore, comparisons among sotalol, propafenone and procainamide showed that sotalol increased the exercise performance and the variability of ventricular rate in patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias.",
keywords = "Antiarrhythmic drugs, Atrial fibrillation",
author = "Hsieh, {Ming Hsiung} and Chen, {Shih Ann} and Wen, {Zu Chin} and Tai, {Ching Tai} and Chiang, {Chern En} and Ding, {Yu An} and Chang, {Mau Song}",
year = "1998",
month = "3",
day = "13",
doi = "10.1016/S0167-5273(97)00330-6",
language = "English",
volume = "64",
pages = "37--45",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias

AU - Hsieh, Ming Hsiung

AU - Chen, Shih Ann

AU - Wen, Zu Chin

AU - Tai, Ching Tai

AU - Chiang, Chern En

AU - Ding, Yu An

AU - Chang, Mau Song

PY - 1998/3/13

Y1 - 1998/3/13

N2 - For conversion of atrial fibrillation to sinus rhythm and management of ventricular arrhythmias, antiarrhythmic drugs were frequently used. However, the effects of antiarrhythmic drugs on exercise performance and on the variability of ventricular rate were not available. This study included 37 patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias. The patients were divided into three groups and received sotalol, propafenone, and procainamide, respectively. Before and after taking the drugs for 14 days, these patients received treadmill exercise test, 24 h Holter electrocardiogram, and tilt table test for evaluation of the exercise performance and the variability of ventricular rate (including the mean RR intervals, mRR, the standard deviation of RR intervals, SDRR, and the root mean square of the difference in successive RR intervals, rMSSD). All these antiarrhythmic drugs could suppress ventricular arrhythmia but only sotalol could significantly increase the exercise duration (374 ± 50 to 476 ± 55 s, P=0,02), and reduce the maximal heart rate (186 ± 23 to 136 ± 16 beats/min, P=0.01) during exercise test. Furthermore, only sotalol increased the mRR (777 ± 60 to 885 ± 66 ms, P=0.02), SDRR (190 ± 40 to 216 ± 48 ms, P=0.04) and rMSSD (223 ± 48 to 253 ± 40 ms, P=0.03) during 24 h Holter electrocardiogram. With head-up tilt, the mRR, SDRR and rMSSD all decreased significantly before drug therapy, and these changes were still present only after propafenone therapy. Therefore, comparisons among sotalol, propafenone and procainamide showed that sotalol increased the exercise performance and the variability of ventricular rate in patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias.

AB - For conversion of atrial fibrillation to sinus rhythm and management of ventricular arrhythmias, antiarrhythmic drugs were frequently used. However, the effects of antiarrhythmic drugs on exercise performance and on the variability of ventricular rate were not available. This study included 37 patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias. The patients were divided into three groups and received sotalol, propafenone, and procainamide, respectively. Before and after taking the drugs for 14 days, these patients received treadmill exercise test, 24 h Holter electrocardiogram, and tilt table test for evaluation of the exercise performance and the variability of ventricular rate (including the mean RR intervals, mRR, the standard deviation of RR intervals, SDRR, and the root mean square of the difference in successive RR intervals, rMSSD). All these antiarrhythmic drugs could suppress ventricular arrhythmia but only sotalol could significantly increase the exercise duration (374 ± 50 to 476 ± 55 s, P=0,02), and reduce the maximal heart rate (186 ± 23 to 136 ± 16 beats/min, P=0.01) during exercise test. Furthermore, only sotalol increased the mRR (777 ± 60 to 885 ± 66 ms, P=0.02), SDRR (190 ± 40 to 216 ± 48 ms, P=0.04) and rMSSD (223 ± 48 to 253 ± 40 ms, P=0.03) during 24 h Holter electrocardiogram. With head-up tilt, the mRR, SDRR and rMSSD all decreased significantly before drug therapy, and these changes were still present only after propafenone therapy. Therefore, comparisons among sotalol, propafenone and procainamide showed that sotalol increased the exercise performance and the variability of ventricular rate in patients who had chronic atrial fibrillation complicated with symptomatic ventricular arrhythmias.

KW - Antiarrhythmic drugs

KW - Atrial fibrillation

UR - http://www.scopus.com/inward/record.url?scp=0032513180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032513180&partnerID=8YFLogxK

U2 - 10.1016/S0167-5273(97)00330-6

DO - 10.1016/S0167-5273(97)00330-6

M3 - Article

VL - 64

SP - 37

EP - 45

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 1

ER -